Medhi Wangpaichitr
University of Miami
H-index: 27
North America-United States
Top articles of Medhi Wangpaichitr
Growth Hormone Releasing Hormone Receptor (GHRH-R) Mediates Alveolar Epithelial Type 2 Cell Inflammation
2024/5
Targeting of metabolic reprogramming in lung cancer by utilizing patient-derived organoid tissue for precision medicine
Cancer Research
2024/3/22
Can serum exosomal content predict response to immunotherapy in hepatocellular carcinoma
Cancer Research
2024/3/22
Ying-Ying Li
H-Index: 13
Medhi Wangpaichitr
H-Index: 19
Alveolar epithelial cell growth hormone releasing hormone receptor in alveolar epithelial inflammation
Experimental lung research
2023/12/31
Exploiting the kynurenine pathway to combat platinum-resistant non-small cell lung cancer (NSCLC)
2023/9/9
Medhi Wangpaichitr
H-Index: 19
Dan Nguyen
H-Index: 21
Alveolar epithelial cells facilitate lung inflammation and fibrosis in response to cytokines
2023/9/9
Medhi Wangpaichitr
H-Index: 19
Robert M Jackson
H-Index: 11
Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer
Cancer & metabolism
2023/5/24
Medhi Wangpaichitr
H-Index: 19
Alveolar Type 2 Cell Growth Hormone Releasing Hormone Receptor (GHRH-R) Modulates Inflammatory and Fibrotic Signaling
2023/5
Can exosomal cargoes predict checkpoint inhibitor response in melanoma, and can we overcome drug resistance
Cancer Research
2023/4/4
Dan Nguyen
H-Index: 21
Medhi Wangpaichitr
H-Index: 19
Stephane Roche
H-Index: 14
Jose Lutzky
H-Index: 29
Neha Goel
H-Index: 0
Targeting IDO1 and TDO2 is crucial for the modulation of immune effector in platinum resistant non-small cell lung cancer
Cancer Research
2023/4/4
Medhi Wangpaichitr
H-Index: 19
Effects of GHRH-R Antagonist MIA-602 or Agonist MR-409 on Human iAT2 Cells Exposed to Cytokines or LPS
2022/5
Exploiting the Innate Plasticity of the Programmed Cell Death‐1 (PD1) Receptor to Design Pembrolizumab H3 Loop Mimics
ChemBioChem
2022/11/4
Medhi Wangpaichitr
H-Index: 19
Targeting kynurenine pathway using novel IDO/TDO dual inhibitor (AT0174) to modulate tumor microenvironment in platinum resistant non-small cell lung cancer cancer: An …
Cancer Research
2022/6/15
Dan Nguyen
H-Index: 21
Medhi Wangpaichitr
H-Index: 19
Circulating biomarkers to predict antitumor response to immunotherapy in advanced unresectable hepatoma
Cancer Research
2022/6/15
Ying-Ying Li
H-Index: 13
Medhi Wangpaichitr
H-Index: 19
Enhancing the effect of tumor necrosis factor-related apoptosis-inducing ligand signaling and arginine deprivation in melanoma
2021/7/16
Cisplatin resistance and redox-metabolic vulnerability: a second alteration
2021/7/9
Medhi Wangpaichitr
H-Index: 19
Targeting immunological and apoptotic cell death to improve therapeutic efficacy in melanoma
Cancer Research
2021/7/1
Ying-Ying Li
H-Index: 13
Medhi Wangpaichitr
H-Index: 19
Eradicating melanoma cells using combination of nutritional stress and checkpoint inhibitors
Cancer Research
2021/7/1
Ying-Ying Li
H-Index: 13
Medhi Wangpaichitr
H-Index: 19
Cardiomyopathic mutations in essential light chain reveal mechanisms regulating the super relaxed state of myosin
Journal of General Physiology
2021/5/20
Medhi Wangpaichitr
H-Index: 19
Bent to Bind: Exploiting the Programmed Cell Death-1 (PD-1) Receptor Plasticity to Design Pembrolizumab H3 Loop Mimics
2021/4/26
Medhi Wangpaichitr
H-Index: 19
Stephane Roche
H-Index: 14
